209 related articles for article (PubMed ID: 33651718)
1. Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.
Koyuncu CF; Lu C; Bera K; Zhang Z; Xu J; Toro P; Corredor G; Chute D; Fu P; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LD; Chernock RD; Lang Kuhs KA; Luo J; Sandulache V; Adelstein DJ; Koyfman S; Lewis JS; Madabhushi A
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651718
[TBL] [Abstract][Full Text] [Related]
2. A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.
Wang X; Bera K; Barrera C; Zhou Y; Lu C; Vaidya P; Fu P; Yang M; Schmid RA; Berezowska S; Choi H; Velcheti V; Madabhushi A
EBioMedicine; 2021 Jul; 69():103481. PubMed ID: 34265509
[TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
Wilde DC; Castro PD; Bera K; Lai S; Madabhushi A; Corredor G; Koyuncu C; Lewis JS; Lu C; Frederick MJ; Frederick AM; Haugen AE; Zevallos JP; Sturgis EM; Shi J; Huang AT; Hernandez DJ; Skinner HD; Kemnade JO; Yu W; Sikora AG; Sandulache VC
Mod Pathol; 2022 Aug; 35(8):1045-1054. PubMed ID: 35184149
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG; Saba NF
PLoS One; 2021; 16(2):e0247498. PubMed ID: 33626078
[TBL] [Abstract][Full Text] [Related]
6. Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients.
Koyuncu CF; Frederick MJ; Thompson LDR; Corredor G; Khalighi S; Zhang Z; Song B; Lu C; Nag R; Sankar Viswanathan V; Gilkey M; Yang K; Koyfman SA; Chute DJ; Castro P; Lewis JS; Madabhushi A; Sandulache VC
Oral Oncol; 2023 Aug; 143():106459. PubMed ID: 37307602
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains.
Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N
Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment.
Sato F; Ono T; Kawahara A; Kawaguchi T; Tanaka H; Shimamatsu K; Kakuma T; Akiba J; Umeno H; Yano H
J Clin Pathol; 2019 Aug; 72(8):542-549. PubMed ID: 31113825
[TBL] [Abstract][Full Text] [Related]
9. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence for automating the measurement of histologic image biomarkers.
Cornish TC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855974
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
12. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
13. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes.
Quon H; Cohen MA; Montone KT; Ziober AF; Wang LP; Weinstein GS; O'Malley BW
Laryngoscope; 2013 Mar; 123(3):635-40. PubMed ID: 22588642
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
16. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
17. Mismatch Repair Proteins in Oropharyngeal Squamous Cell Carcinoma: A Retrospective Observational Study.
de Oliveira Filho OV; Dantas TS; de Lima Silva-Fernandes IJ; Saldanha Cunha MDPS; Alves APNN; Mota MRL; de Barros Silva PG; Sousa FB
Head Neck Pathol; 2021 Sep; 15(3):803-816. PubMed ID: 33501557
[TBL] [Abstract][Full Text] [Related]
18. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
19. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact Outcome.
Thompson LDR; Burchette R; Iganej S; Bhattasali O
Head Neck Pathol; 2020 Sep; 14(3):666-688. PubMed ID: 31741151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
